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Sir, 
Skin malignancies are the most common cancers in humans, the majority of which are non-
melanoma skin cancers. These have a relatively low morbidity and propensity to metastasize 
and are generally considered to have little impact on quality of life.1 Complete surgical 
excision can often be achieved without leaving an extensive cosmetic or functional defect 
and is generally performed in a high-turnover, day case setting. Consequently patients with 
basal and early squamous cell carcinomas are rarely offered formal support or counselling.   
However, since 80% of non-melanoma skin cancers occur in the head and neck region, both 
the skin cancer and the scars following surgical excision are frequently highly conspicuous. 
Minor as well as major degrees of facial disfigurement can result in high levels of anxiety, 
depression and social isolation, the severity of which often bears little relationship to the 
magnitude of the defect itself.2 This study was designed to quantify the social, emotional and 
aesthetic impact of facial skin malignancies on patients before and after surgical excision. 
Fifty three patients presenting to plastic surgery outpatients with a cutaneous malignancy 
located in the head and neck region were prospectively recruited. Structured questionnaires 
were used to obtain basic demographic and clinical data. The impact of the malignancy was 
assessed before and three months after surgery using the Skin Cancer Index (SCI).3 This is 
a 15 item, validated, disease-specific quality of life (QOL) assessment tool which measures 
three distinct subscales: emotion, social and appearance. Standardised scores range from 
0-100 with higher scores reflecting an improvement in QOL. Ethical approval for the project 
was granted by the Leeds East Research and Ethics Committee. 
A power analysis was conducted to determine an adequate sample size. Mean SCI scores 
with standard deviations were calculated for total SCI and individual SCI subscales pre- and 
post- operatively and for the change between pre-operative and post-operative scores.  
There were 29 (55%) men and 24 women recruited to the study. The majority were in the 
older age group with 70% patients aged 66 years or above. The predominant lesion excised 
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(62%) was basal cell carcinoma (BCC). Squamous cell carcinomas (SCCs) comprised 19% 
and the remaining patients had a diagnosis of melanoma (11%) or benign lesions (8%). 
Reconstruction following excision was by primary closure (28%), skin graft (53%) or local 
flap (19%).   
Surgical excision led to a significant improvement in both the total SCI score (from 70.0 to 
82.4, p<0.001) and in each of the individual subscale scores (Table 1).  The greatest overall 
improvement was seen in the appearance subscale, from 68.7 to 85.2 (p<0.001). Patients 
with SCCs exhibited an improvement in total SCI score over 3 times greater than the 
corresponding improvement shown by patients with BCCs (p=0.016) (Table 2). Women had 
lower scores than men both pre- and post-operatively, but showed greater improvement than 
men in the emotional and appearance subscales (Table 2). Men showed greater 
improvement than women in the social sub-scale. None of the differences observed between 
genders achieved statistical significance. Patients with scar lengths over 50cm showed a 
greater change in the appearance subscale (p=0.037); not significant when corrected for 
multiple comparisons. Age and social isolation factors did not significantly affect total or sub-
scale scores. 
Morbidity assumes greater importance than mortality in many patients with cutaneous 
malignancies, making quality of life a more relevant endpoint in assessment of the disease 
process. Compared with other dermatological QOL tools the SCI captures issues specific to 
facial skin cancers such as scarring, disfigurement and concerns about possible recurrence. 
The individual subscales allow identification of anxieties related to self-image and social 
confidence as well as those directly related to cancer. 
Consistently lower pre-operative SCI scores found in this study indicate the presence of 
anxiety among patients attending with suspicious skin lesions, despite the relatively indolent 
behaviour of their tumours. In our cohort this was more evident, although not significantly so, 
in female patients. In other malignancies, the early period surrounding diagnosis is widely 
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recognised to be the most stressful to patients.4,5 The challenge raised here is to design 
support strategies appropriate to both a widely varying group of patients and to the high 
turnover setting in which they are managed. Self help leaflets, ready access to support 
organisations, the presence of a psychological specialist in the clinic setting and engaging 
friends or relatives in the support process are possible options to consider. 
Overall the results of this study indicate that surgical excision improves social, emotional and 
cosmetic well being in patients with facial skin malignancies. This is likely to reflect 
reassurance experienced by the knowledge a lesion has been completely removed.  
Currently surgery remains the cornerstone of treatment for patients with cutaneous 
malignancies. As topical, non-surgical treatments continue to emerge as alternatives, further 
study in this area may serve as a useful indicator of the patients (rather than clinicians) 
preference. 
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Table Legends 
Table 1: Pre-and post operative mean (SD) SCI total and sub-scale scores and assessment 
of effect of surgery. 
Table 2: Pre-and post operative mean (SD) SCI total and sub-scale scores partitioned by 
demographic and clinical factors. 
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Tables 
Table 1: Pre-and post operative mean (SD) SCI total and sub-scale scores and 
assessment of effect of surgery 
SCI scale Pre-surgery 
mean (SD) 
Post-surgery 
mean (SD) 
Change mean 
(SD) 
p-value 
Total score 70.0 (25.3) 82.4 (18.4) 12.4 (17.4) <0.001 
Emotional score 66.6 (27.1) 77.6 (20.0) 11.0 (17.6) <0.001 
Social score 75.5 (28.3) 85.7 (23.1) 10.2 (26.3) 0.007 
Appearance score 68.7 (34.3) 85.2 (23.1) 16.5 (27.7) <0.001 
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Table 2: Pre-and post operative mean (SD) SCI total and sub-scale scores partitioned 
by demographic and clinical factors 
SCI scale Factor Pre-surgery 
mean (SD) 
Post-surgery 
mean (SD) 
Change 
mean (SD) 
p-value 
Total score 
 
Histology 
BCC 
SCC 
 
74.8 (22.3) 
59.8 (31.9) 
 
81.9 (20.8) 
83.0 (13.4) 
 
7.1 (13.2) 
23.2 (23.4) 
 
 
0.016 
Gender 
Male 
Female 
 
76.2 (24.6) 
62.5 (24.5) 
 
89.0 (11.3) 
74.4 (22.1) 
 
12.8 (15.8) 
11.9 (19.5) 
 
 
0.198 
Scar size 
<10cm 
11-30cm 
31-50cm 
>50cm 
 
62.9 (21.6) 
68.8 (27.0) 
82.7 (21.9) 
62.5 (29.0) 
 
71.7 (24.8) 
83.6 (17.0) 
87.0 (19.1) 
81.9 (15.9) 
 
8.7 (18.9) 
14.9 (19.6) 
4.3 (10.2) 
19.4 (14.8) 
 
 
 
 
0.298 
Emotional 
score 
 
Histology 
BCC 
SCC 
 
71.8 (25.4) 
60.4 (28.3) 
 
78.0 (21.0) 
76.8 (17.1) 
 
6.3 (13.7) 
16.4 (20.4) 
 
 
0.031 
Gender 
Male 
Female 
 
73.9 (24.9) 
57.9 (27.6) 
 
83.4 (16.9) 
70.7 (21.6) 
 
9.5 (14.5) 
12.8 (20.9) 
 
 
0.124 
Scar size 
<10cm 
11-30cm 
31-50cm 
>50cm 
 
60.3 (27.2) 
61.2 (26.5) 
76.4 (26.1) 
60.1 (36.1) 
 
67.4 (27.0) 
78.3 (19.9) 
84.3 (17.7) 
77.4 (16.7) 
 
7.1 (6.6) 
11.1 (19.1) 
7.9 (16.7) 
17.3 (24.2) 
 
 
 
 
0.847 
Social score Histology     
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BCC 
SCC 
79.2 (25.8) 
61.0 (35.1) 
83.3 (27.8) 
88.0 (13.0) 
4.1 (25.1) 
27.0 (25.6) 
 
0.053 
Gender 
Male 
Female 
 
77.4 (26.7) 
73.1 (30.5) 
 
90.7 (18.1) 
79.6 (27.1) 
 
13.3 (23.5) 
6.5 (29.4) 
 
 
0.709 
Scar size 
<10cm 
11-30cm 
31-50cm 
>50cm 
 
72.5 (28.5) 
71.5 (29.3) 
84.5 (28.4) 
77.5 (29.8) 
 
76.3 (31.5) 
85.9 (21.3) 
88.5 (28.0) 
88.3 (13.3) 
 
3.8 (43.2) 
14.4 (25.7) 
4.0 (11.7) 
10.8 (25.6) 
 
 
 
 
0.819 
Appearance 
score 
Histology 
BCC 
SCC 
 
74.5 (31.7) 
56.7 (38.8) 
 
84.1 (26.5) 
89.2 (14.2) 
 
9.6 (25.3) 
32.5 (32.7) 
 
 
0.038 
Gender 
Male 
Female 
 
79.6 (30.6) 
55.6 (34.5) 
 
94.0 (10.7) 
74.7 (29.3) 
 
14.4 (22.6) 
19.1 (33.1) 
 
 
0.116 
Scar size 
<10cm 
11-30cm 
31-50cm 
>50cm 
 
53.1 (32.4) 
67.9 (36.5) 
94.2 (8.8) 
43.1 (31.4) 
 
73.9 (24.2) 
86.7 (23.7) 
90.8 (23.7) 
81.9 (22.0) 
 
20.8 (28.5) 
18.8 (28.4) 
-3.3 (18.5) 
38.9 (18.0) 
 
 
 
 
0.037 
 
 
 
 
 
